Searchable abstracts of presentations at key conferences on calcified tissues
Bone Abstracts (2016) 5 P387 | DOI: 10.1530/boneabs.5.P387

ECTS2016 Poster Presentations Osteoporosis: treatment (40 abstracts)

Effect of 61-week administration with beta-hydroxy-beta-methylbutyrate on volumetric bone mineral density of lumbar spine in osteoporotic patient

Marcin Tatara 1, , Witold Krupski 2 & Barbara Majer-Dziedzic 3


1Department of Animal Physiology, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Lublin, Poland; 2Department of Radiology, Medical University of Lublin, Lublin, Poland; 3Department of Microbiology, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Lublin, Poland.


Currently available osteoporosis treatment include antiresorptives and/or anabolic agents. Studies in animals have shown that beta-hydroxy-beta-methylbutyrate (HMB) administration affects anabolically bone tissue metabolism and improves morphological, densitometric and mechanical properties of bones in axial and appendicular skeleton. Thus, the aim of the study was to present first data on effects of 61-week treatment with HMB on volumetric bone mineral density (vBMD) of lumbar spine in female patient suffering from postmenopausal osteoporosis. The therapy with calcium salt of HMB (CaHMB – HMB Mega Caps 1250, Olimp Sport Nutrition, Poland) was performed orally (1250 mg/day). One CaHMB capsule consisting of 1000 mg of pure HMB was taken during the diner each day throughout 61 weeks. Quantitative computed tomography method and SOMATOM EMOTION SIEMENS apparatus (Siemens, Erlangen, Germany) equipped with Somaris/5 VB10B software (version B10/2004A) and Osteo CT application package were used to determine vBMD of the trabecular and cortical bone compartments in each lumbar vertebrae (L1–L5). Calcium hydroxyapatite (Ca-HA) density of trabecular bone (TbCa-HA) was measured in the central part of the cross-section of the vertebral body, while calcium hydroxyapatite density of cortical bone (CbCa-HA) was determined on the margins of the vertebral body. The measurements of vBMD were performed at the baseline and 61 weeks later.

61-week long oral administration with CaHMB in the osteoporotic patient increased TbCa-HA and CbCa-HA by 1.98% and 7.99%, respectively. The increased values of T-score (20 years) and Z-score by 0.07 and 0.12 were also stated as the result of the 14-month therapy with HMB.

In conclusion, this study indicates that HMB improves vBMD of lumbar spine and may be applied for effective treatment of osteoporosis in humans. However, further studies on wider human population are recommended to evaluate dose-related effectiveness and possible mechanisms influencing bone tissue metabolism by HMB.

Volume 5

43rd Annual European Calcified Tissue Society Congress

Rome, Italy
14 May 2016 - 17 May 2016

European Calcified Tissue Society 

Browse other volumes

Article tools

My recent searches

No recent searches.